Blog Posts

Congressional Researchers Provide Contract Pharmacy Report on 340B as Legislators Mull Bills

Congressional Research Service wordmark and logo
The Congressional Research Service issued a summary of the range of policy actions affecting 340B contract pharmacy use in recent years
Congress’ in-house non-partisan research arm recently produced a summary of the range of policy actions affecting 340B contract pharmacy use [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Bayer Adds Prostate Cancer Drug to Contract Pharmacy Restrictions

Bayer wordmark on building
Bayer added a previously excluded drug to its list of products that face contract pharmacy restrictions.
Bayer recently announced it will add a previously excluded drug to its list of products that face contract pharmacy restrictions. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

No Adverse Findings in First HRSA Drugmaker Audit of 2024

Federal auditors recently reported no adverse findings in their first fiscal year 2024 340B audit of a pharmaceutical manufacturer.
Federal auditors recently reported no adverse findings in their first fiscal year 2024 340B audit of a pharmaceutical manufacturer. On [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

ASAP 340B-Backed Bill Introduced in House

Capitol building
Key House Republicans on Tuesday introduced long-awaited—and contentious—legislation to overhaul the 340B program.
Key House Republicans on Tuesday introduced long-awaited—and contentious—legislation to overhaul the 340B program based on recommendations from a nonprofit group [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live